Management of Patients with Low GFR
Patients with low glomerular filtration rate (GFR) should be managed with a structured approach that includes medication adjustments, monitoring for complications, and appropriate referral to nephrology when GFR falls below 30 mL/min/1.73 m².1
When to Refer to Nephrology
- Refer patients to nephrology services when GFR <30 mL/min/1.73 m² (CKD stages 4-5) 1, 2
- Additional referral criteria include:
- Abrupt sustained fall in GFR or acute kidney injury 1
- Significant albuminuria (ACR ≥300 mg/g or ≥30 mg/mmol) 1
- Urinary abnormalities (red cell casts, RBC >20 per high power field) 1
- Refractory hypertension (requiring 4+ antihypertensive agents) 1
- Persistent electrolyte abnormalities 1
- Recurrent nephrolithiasis 1
- Hereditary kidney disease 1
Medication Management
Metformin Adjustments
- Metformin is contraindicated in patients with GFR <30 mL/min/1.73 m² 3
- Initiation of metformin is not recommended in patients with GFR between 30-45 mL/min/1.73 m² 3
- For patients already on metformin whose GFR falls below 45 mL/min/1.73 m², assess the benefit-risk of continuing therapy 3
- Temporarily discontinue metformin before iodinated contrast imaging procedures in patients with GFR between 30-60 mL/min/1.73 m² 3
Other Medication Considerations
- Adjust medication dosages based on GFR levels, particularly for drugs with renal clearance 4, 2
- Avoid nephrotoxic medications (e.g., NSAIDs) in patients with decreased GFR 4, 2
- For diabetes management in low GFR:
Blood Pressure Management
- Target blood pressure <130/80 mmHg in patients with GFR <30 mL/min/1.73 m² 4
- Use ACE inhibitors or ARBs as first-line agents for hypertension management 4
- Monitor serum potassium in patients with GFR <60 mL/min/1.73 m² receiving ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 2
Metabolic Management
- Consider bicarbonate supplementation to maintain serum bicarbonate within normal range for patients with metabolic acidosis 4
- Target LDL cholesterol to <100 mg/dL and non-HDL cholesterol to <130 mg/dL 4
- Monitor for vitamin D deficiency and consider supplementation if 25(OH) vitamin D levels are <30 ng/mL 4
- Address hypocalcemia (serum calcium <8.5 mg/dL) with elemental calcium supplementation after addressing phosphorus issues 4
Nutritional Management
- Restrict dietary protein to 0.8 g/kg/day for patients with GFR <60 mL/min/1.73 m² 4, 2
- Avoid protein restriction below 0.6 g/kg/day due to risk of malnutrition 4
- Restrict dietary sodium to <2.0 g/day to reduce edema, control blood pressure, and reduce proteinuria 4, 2
- Target caloric intake of 30-35 kcal/kg/day for patients with GFR <60 mL/min/1.73 m² 4
Monitoring and Assessment
- Monitor blood pressure at every clinic visit (at least every three months) for patients with GFR <30 mL/min/1.73 m² 4
- Check serum albumin and body weight every three months to monitor nutritional status 4
- Screen for dyslipidemias by measuring triglycerides, LDL, HDL, and total cholesterol 4
- Obtain eGFR at least annually in all patients taking metformin 3
- In patients at risk for renal impairment (e.g., the elderly), assess renal function more frequently 3
Planning for Renal Replacement Therapy (RRT)
- Discuss RRT modality options with patients who have GFR <30 mL/min/1.73 m² 4
- No specific GFR threshold alone should determine when to initiate RRT 4
- Consider initiating RRT in patients with GFR <20 mL/min/1.73 m² who have evidence of malnutrition that does not respond to nutritional intervention 4
- Refer patients willing to have renal transplantation for transplant evaluation 4
- Preserve veins suitable for vascular access placement if hemodialysis is planned 4
- Refer for surgery to construct primary AV fistula if hemodialysis is the chosen modality 4
Special Considerations and Pitfalls
- Patients with low GFRs are generally at increased bleeding risk, and antiplatelet medications further increase this risk 4
- Elevated troponin in CKD patients has good prognostic accuracy despite reduced diagnostic accuracy for acute coronary syndrome 4
- Recognize that GFR equations (MDRD vs. Cockcroft-Gault) may provide discordant estimations in over 60% of elderly patients, which can affect medication dosing 5
- Be aware that a decline in GFR in the context of a stable or improving clinical condition should not necessarily lead to discontinuation of life-saving therapies 6